Publications

Hookworm vaccines: past, present, and future.

Loukas, A; Bethony, J; BROOKER, S; Hotez, P;

2006

The Lancet infectious diseases, (2006).6 11 10.1016/S1473-3099(06)70630-2.

Differential evidence of natural selection on two leading sporozoite stage malaria vaccine candidate antigens.

Weedall, GD; Preston, BM J; Thomas, AW; SUTHERLAND, CJ; CONWAY, DJ;

2006

International journal for parasitology, (2006).37 1 10.1016/j.ijpara.2006.09.001.

Incidence of clinically significant bacteraemia in children who present to hospital in Kenya: community-based observational study.

Brent, AJ; Ahmed, I; Ndiritu, M; Lewa, P; Ngetsa, C; Lowe, B; Bauni, E; English, M; Berkley, JA; SCOTT, JA G;

2006

Lancet, (2006).367 9509 10.1016/S0140-6736(06)68180-4.

A phase 2b randomised trial of the candidate malaria vaccines FP9 ME-TRAP and MVA ME-TRAP among children in Kenya.

Bejon, P; Mwacharo, J; Kai, O; Mwangi, T; MILLIGAN, P; Todryk, S; Keating, S; Lang, T; Lowe, B; Gikonyo, C; Molyneux, C; Fegan, G; Gilbert, SC; Peshu, N; Marsh, K; Hill, AV S;

2006

PLoS clinical trials, (2006).1 6 10.1371/journal.pctr.0010029.

The current burden of pneumococcal disease in England and Wales.

Melegaro, A; EDMUNDS, WJ; Pebody, R; MILLER, E; George, R;

2006

The Journal of infection, (2006).52 1 10.1016/j.jinf.2005.02.008.

Injectable vaccines for preventing pneumococcal infection in patients with chronic obstructive pulmonary disease.

Granger, R; Walters, J; Poole, PJ; Lasserson, TJ; MANGTANI, P; Cates, CJ; Wood-Baker, R;

2006

The Cochrane database of systematic reviews, (2006).4 4 10.1002/14651858.CD001390.pub2.

'Non-specific effects of vaccines'--an important analytical insight, and call for a workshop.

FINE, PE M; SMITH, PG;

2006

Tropical medicine & international health, (2006).12 1 10.1111/j.1365-3156.2006.01794.x.

Cross-sectional survey of older peoples' views related to influenza vaccine uptake.

MANGTANI, P; Breeze, E; Stirling, S; Hanciles, S; KOVATS, S; FLETCHER, A;

2006

BMC public health, (2006).6 1 10.1186/1471-2458-6-249.

The influence of previous exposure to environmental mycobacteria on the interferon-gamma response to bacille Calmette-Guérin vaccination in southern England and northern Malawi.

Weir, RE; Black, GF; Nazareth, B; FLOYD, S; Stenson, S; Stanley, C; BRANSON, K; Sichali, L; Chaguluka, SD; Donovan, L; CRAMPIN, AC; FINE, PE M; DOCKRELL, HM;

2006

Clinical and experimental immunology, (2006).146 3 10.1111/j.1365-2249.2006.03222.x.

BCG vaccine effectiveness against Buruli ulcer: a case-control study in Benin.

Nackers, F; Dramaix, M; Johnson, RC; Zinsou, C; Robert, A; DE Biurrun Bakedano, E; GLYNN, JR; Portaels, F; Tonglet, R;

2006

The American journal of tropical medicine and hygiene, (2006).75 4 10.4269/ajtmh.2006.75.768.